World News: 09:00 GMT Wednesday 23rd January 2019. [Elsalys Biotech via Globe Newswire via SPi World News]
This randomized multicentre controlled parallel-group Phase 3 study France Belgium100 adult patients with grade II-IV SR-aGvHD with inolimomab versus control ATG anti-thymocyte approved in this indication in France only) ...
Globe Newswire: 09:00 GMT Wednesday 23rd January 2019
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.